Company:  ORAMED PHARMACEUTICALS IN ... (ORMP)
Form Type:  8-K
Filing Date:  8/1/2013 
CIK:  0001176309 
Address:  142 W. 57TH STREET, 11TH FLOOR 
City, State, Zip:  NEW YORK, New York 10019 
Telephone:  646-844-1164 
Fiscal Year:  08/31 
Last Trade
Last Trade: 
$3.93  
Change: 
-0.07 (-1.75%)  
Trade Time: 
03:17 PM EST  
Market Cap: 
$68.30M
Trade ORMP now with 

© 2018  
Description of Business
We are a pharmaceutical company currently engaged in the research and development of innovative pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Oral insulin: We are seeking to revolutionize the treatment of diabetes through our proprietary flagship product, an orally ingestible insulin capsule, or ORMD-0801. Our technology allows insulin to travel from the gastrointestinal tract via the portal vein to the bloodstream, revolutionizing the manner in which insulin is delivered. It enables its passage in a more physiological manner than current delivery methods of insulin. Our technology is a platform that has the potential to deliver medications and vaccines orally that today can only be delivered via injection. In April 2018, we initiated a three-month dose-ranging Phase IIb clinical trial of ORMD-0801.
Register and access this filing in:     
  FORM 8-K
    SECTION 8 OTHER EVENTS
      Item 8.01. Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1